Several mergers and acquisitions are afoot in Medicare Advantage.
Payer
During a featured panel discussion at Becker's Payer Issues Roundtable, panelists discussed care access trends among older patient populations. Panelists highlighted the fragmented health system, shortage of providers across skill levels and significant variations in access to care as systemic…
Medicare Advantage beneficiaries are more likely to be prescribed biosimilar drugs than their counterparts in traditional Medicare, a study published Dec. 28 in JAMA Health Forum found.
UnitedHealth Group is suing a group of corporate entities founded by two of its former executives after they allegedly stole and used confidential information from the company to create their own competing product for diabetes management.
Centene will pay South Carolina $25.9 million to settle allegations the company overcharged the state's Medicaid program for pharmacy services.
Advertisement
Devoted Health, a startup Medicare Advantage plan, raised $175 million in series E funding.
McKinsey and Company agreed to pay $78 million to health plans to settle allegations the consulting firm helped Purdue Pharma create misleading advertising campaigns for opioids, The Hill reported Dec. 30.
In July, Reps. Michael Burgess, MD, and Vicente Gonzalez, both of Texas, introduced gold-card legislation that would exempt qualifying providers from prior authorization requirements for Medicare Advantage plans.
From the start of Medicaid redeterminations to short-lived megamergers, these are the 10 most read health insurance stories reported by Becker's in 2023:
From CareFirst suing Johnson & Johnson over alleged anticompetitive biosimilar tactics to Humana accused of using an AI tool to wrongfully deny Medicare Advantage claims, here five lawsuits, settlements and legal developments involving payers that Becker's has reported since Dec.…